Replimune Group, Inc. filed a Form 8-K on September 16, 2026, reporting that stockholders at the company's September 15, 2026 annual meeting approved an amendment to its certificate of incorporation doubling authorized common shares and ratifying its independent auditor, among other matters.

Key Highlights

  • Authorized share increase approved: Stockholders approved raising authorized common stock, par value $0.001 per share, from 150,000,000 shares to 300,000,000 shares.
  • Certificate of Amendment filed: The amendment became effective immediately upon filing with the Secretary of State of the State of Delaware on September 15, 2026.
  • Share increase vote: Proposal No. 3 passed with 62,153,709 votes for, 1,526,174 votes against, and 80,054 abstentions.
  • Auditor ratified: PricewaterhouseCoopers LLP was ratified as independent registered public accounting firm for the fiscal year ending March 31, 2027, with 63,434,745 votes for.
  • Say on Pay approved: Named executive officer compensation for the fiscal year ended March 31, 2026 was approved on a non-binding advisory basis, with 48,641,528 votes for and 14,440,328 broker non-votes.

Replimune Stockholders Authorize Share Count Doubling at 2026 Annual Meeting

According to the filing, Replimune Group, Inc. (NASDAQ:REPL) held its annual meeting of stockholders on September 15, 2026, at which three proposals described in the company's definitive proxy statement on Schedule 14A, filed with the SEC on July 29, 2026, were considered and voted upon. The most consequential action, according to the filing, was stockholder approval of an amendment to the company's Third Amended and Restated Certificate of Incorporation to double the number of authorized shares of common stock from 150,000,000 to 300,000,000.

The company disclosed that its Board of Directors had previously approved the amendment, subject to stockholder approval at the annual meeting and the subsequent filing of a certificate of amendment with the Secretary of State of Delaware. That certificate was filed on September 15, 2026, and, according to the filing, "became effective immediately upon such filing." The filing notes that the description of the certificate of amendment "does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment," which is attached as Exhibit 3.1.

On the two remaining proposals, stockholders ratified PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2027, by a vote of 63,434,745 for, 253,953 against, and 71,239 abstaining. The non-binding advisory vote on named executive officer compensation for the fiscal year ended March 31, 2026 resulted in 48,641,528 votes for, 622,710 votes against, 55,371 abstentions, and 14,440,328 broker non-votes.

What Was Disclosed

Replimune Group reported annual meeting voting results and disclosed that its authorized common stock was doubled to 300,000,000 shares via a certificate of amendment filed and effective September 15, 2026, along with ratification of its auditor and a non-binding executive pay vote.